Lonza to buy Capsugel for $5.5bn, no site divestitures planned

Lonza has agreed to buy US capsule manufacturer Capsugel for $5.5bn (€5.2bn) in cash in an acquisition the Swiss firm says will expand its drug delivery business and enable savings of CHF100m a year by 2019.

from NutraIngredients RSS http://ift.tt/2hAXj6h
via IFTTT

Photo

from Bodybuilding Motivation http://ift.tt/2EtKRn5 via IFTTT

Bodybuilding.com Sponsorship Inquiry Page - Success

Bodybuilding.com Sponsorship Inquiry Page - Success from Bodybuilding.com Articles http://ift.tt/1k3uM9z via IFTTT

Mimicry: Gut bacteria metabolites copy human signalling molecules

New gut-mediated therapies could be on the horizon, according to new research that finds GPCR (G-protein-coupled receptor) ligands, formed by gut bacteria, mimic human signalling molecules. from NutraIngredients RSS http://ift.tt/2wLKjnP via IFTTT

guide supplements bodybuilding

Search This Blog